🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
61,65 USD
Máx. histórico
2.925,00
12011 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,89%
Rango 52 semanas
37,06 – 95,49
Variación hoy
+3,56%
Cierre anterior
59,53
Rango de hoy
59,06 – 61,99
Volumen hoy
1.487.357
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,86%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 2 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/08/2023 | 28,56 | 29,73 | 28,00 | 29,39 | +1,87% | 6,06% | 911.300 |
| 11/08/2023 | 28,79 | 29,19 | 28,56 | 28,85 | -0,41% | 2,19% | 667.700 |
| 10/08/2023 | 29,01 | 29,37 | 28,65 | 28,97 | -0,14% | 2,48% | 769.400 |
| 09/08/2023 | 27,50 | 29,37 | 27,28 | 29,01 | +5,53% | 7,58% | 1.488.300 |
| 08/08/2023 | 29,63 | 29,65 | 26,93 | 27,49 | -10,78% | 9,18% | 2.687.500 |
| 07/08/2023 | 31,65 | 31,79 | 30,71 | 30,81 | -2,65% | 3,41% | 765.100 |
| 04/08/2023 | 32,31 | 32,74 | 31,57 | 31,65 | -2,07% | 3,62% | 663.500 |
| 03/08/2023 | 32,85 | 32,92 | 32,10 | 32,32 | -1,97% | 2,50% | 745.500 |
| 02/08/2023 | 33,26 | 33,59 | 32,63 | 32,97 | -2,11% | 2,89% | 876.900 |
| 01/08/2023 | 34,37 | 34,46 | 33,52 | 33,68 | -2,43% | 2,73% | 1.110.100 |
| 31/07/2023 | 35,13 | 35,69 | 34,35 | 34,52 | -1,74% | 3,81% | 620.200 |
| 28/07/2023 | 36,07 | 36,20 | 35,02 | 35,13 | -1,95% | 3,27% | 599.400 |
| 27/07/2023 | 35,34 | 36,27 | 35,21 | 35,83 | +2,08% | 3,01% | 1.337.300 |
| 26/07/2023 | 35,69 | 36,00 | 35,05 | 35,10 | -1,46% | 2,66% | 840.700 |
| 25/07/2023 | 34,87 | 35,70 | 34,87 | 35,62 | +1,60% | 2,37% | 676.900 |
| 24/07/2023 | 35,99 | 36,43 | 34,85 | 35,06 | -2,83% | 4,40% | 762.300 |
| 21/07/2023 | 35,31 | 36,12 | 34,84 | 36,08 | +3,62% | 3,61% | 964.200 |
| 20/07/2023 | 34,75 | 35,40 | 34,51 | 34,82 | +0,72% | 2,56% | 674.200 |
| 19/07/2023 | 35,25 | 35,42 | 34,27 | 34,57 | -1,20% | 3,26% | 514.600 |
| 18/07/2023 | 34,70 | 35,17 | 34,58 | 34,99 | +0,84% | 1,71% | 693.800 |
| 17/07/2023 | 34,40 | 35,70 | 34,40 | 34,70 | +0,29% | 3,78% | 1.189.800 |
| 14/07/2023 | 34,60 | 34,67 | 34,13 | 34,60 | +0,32% | 1,56% | 993.900 |
| 13/07/2023 | 34,09 | 34,77 | 33,83 | 34,49 | +1,68% | 2,76% | 625.800 |
| 12/07/2023 | 34,87 | 34,87 | 33,82 | 33,92 | -1,08% | 3,03% | 726.100 |
| 11/07/2023 | 33,92 | 34,42 | 33,34 | 34,29 | +0,91% | 3,18% | 692.100 |
| 10/07/2023 | 33,10 | 34,12 | 32,73 | 33,98 | +1,98% | 4,20% | 1.148.000 |
| 07/07/2023 | 34,41 | 34,84 | 33,01 | 33,32 | -3,53% | 5,32% | 1.278.100 |
| 06/07/2023 | 34,80 | 34,94 | 33,82 | 34,54 | -1,74% | 3,22% | 889.500 |
| 05/07/2023 | 35,10 | 35,55 | 34,80 | 35,15 | -0,14% | 2,14% | 1.420.500 |
| 03/07/2023 | 35,66 | 35,94 | 34,91 | 35,20 | -1,29% | 2,89% | 605.100 |